Electrophysiologic Measures of Treatment Response in Alzheimer Disease

Phase 4

Completed

• Conditions: Alzheimer Disease

• Registration Number: NCT00018278
• Lead Sponsor: US Department of Veterans Affairs

Brief Summary

The main purpose of this study is to determine the electrophysiological effects of cholinergic therapy (cholinesterase inhibitors and transdermal nicotine) in Alzheimer disease. The attempt will be to locate electrophysiological markers and predictors of cognitive and clinical treatment response.

Detailed Description

Not available

Study Timeline

• Study Start: 1998-10
• Study First Submitted: 2001-07-03
• Study First Submitted QC: 2001-07-04
• Study First Posted: 2001-07-05
• Study Completion: 2001-09
• Status Verified: 2004-12
• Last Update Submitted: 2009-01-20
• Last Update Posted: 2009-01-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Trial Locations

Locations (1)

Department of Veterans Affairs; 🇺🇸 San Diego, California, United States